TRENTON, N.J. (AP) — The ranking Democrat on the House Oversight and Government Reform Committee is turning up the heat on beleaguered Valeant Pharmaceuticals, as the committee continues investigating soaring drug prices.
Rep. Elijah Cummings of Maryland has sought documents about Valeant's drastic price increases for two life-saving heart medications for months. More recently, he's requested interviews with Valeant executives about the company not disclosing its relationship with specialty mail-order pharmacy Philidor. Philidor allegedly set up a network of "phantom pharmacies" to steer pharmacy benefit managers toward Valeant's more expensive drugs, rather than cheaper alternatives.
Cummings is now sending Valeant's CEO a letter asking for the witnesses and documents by Jan. 8, ahead of a committee hearing. The letter was released as Valeant holds an investor day Wednesday to discuss its operations.